February 6, 2020
IGM Biosciences to Present at Two Upcoming Investor Conferences
MOUNTAIN VIEW, Calif. , Feb. 06, 2020 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a global leader in the research and development of engineered therapeutic IgM antibodies, today announced that Fred Schwarzer , Chief Executive Officer, will present at two upcoming investor conferences:
Additional Formats